In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Sutro Biopharma Inc’s stock clocked out at $4.25, up 9.25% from its previous closing price of $3.89. In other words, the price has increased by $9.25 from its previous closing price. On the day, 0.57 million shares were traded. STRO stock price reached its highest trading level at $4.25 during the session, while it also had its lowest trading level at $3.895.
Ratios:
To gain a deeper understanding of STRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.50. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 1.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on November 09, 2023, initiated with a Buy rating and assigned the stock a target price of $12.
On October 06, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.
Wells Fargo Downgraded its Overweight to Equal Weight on March 21, 2023, whereas the target price for the stock was revised from $15 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 29 ’24 when Vasquez Nicki sold 12,185 shares for $5.00 per share. The transaction valued at 60,925 led to the insider holds 12,803 shares of the business.
Shtylla Brunilda sold 15,428 shares of STRO for $72,595 on Aug 28 ’23. The Chief Business Officer now owns 0 shares after completing the transaction at $4.71 per share. On Aug 25 ’23, another insider, Shtylla Brunilda, who serves as the Chief Business Officer of the company, sold 11,613 shares for $4.59 each. As a result, the insider received 53,282 and left with 12,928 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STRO now has a Market Capitalization of 347500000 and an Enterprise Value of -76604656. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.26 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at -0.498 whereas that against EBITDA is 0.929.
Stock Price History:
Over the past 52 weeks, STRO has reached a high of $6.13, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -0.04%, while the 200-Day Moving Average is calculated to be 7.77%.
Shares Statistics:
It appears that STRO traded 987.78K shares on average per day over the past three months and 642280 shares per day over the past ten days. A total of 81.76M shares are outstanding, with a floating share count of 78.42M. Insiders hold about 4.09% of the company’s shares, while institutions hold 75.02% stake in the company. Shares short for STRO as of 1713139200 were 2182983 with a Short Ratio of 2.21, compared to 1710460800 on 2321987. Therefore, it implies a Short% of Shares Outstanding of 2182983 and a Short% of Float of 2.69.
